chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after the vaccine, I experienced a swollen lymph node. It was very painful and I had to take off work for 2 weeks. I went to the doctor and he stated it was a swollen lymph node which states it was from the vaccine. The doctor stated to delay getting the booster.  I was very scared and it was very uncomfortable. To this day, I still have symptoms. I still encounter some swelling and pain that comes and goes. I have to message that area to help relieve some pain. I am transgender and now my hormone levels are abnormal.
Sore arm. Hot and inflamation at the site on the upper left arm. This persisted for 4 days.  The second 2 night after the vaccine in addition to the arm reaction, I had chills and feeling hot and sweating, accompanied by fatigue and myalgia
(1) Muscle and joint pain (hip, legs, feet) (2) (L) foot numbness.
Blotchy slightly raised rash on left arm in area of the injection site. Mildly itchy and warm to the touch
Patient reported dizziness after 1st dose of Pfizer at nurse's station. Patient was transported in wheelchair to sick bay. Patient reported difficulty swallowing and chest tightness; epinephrine .3ml administrated in right thigh at 2:55pm and 911 was called. Wheezing was noted. Upon auscultation, FNP noted expiratory wheezing was noted on upper posterior and anterior lung lobe. Patient's tongue appeared swollen, Patient diaphoretic. BP 88/54, HR 69, O2 99%, Temp 98.7. Ambulance arrived on scene.
Vomiting; Fever; Pain in joints; Severe headache; Lymph node swelling; Pain in body; Severe pain in legs; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 30Apr2021 at 12:45 at the age of 26-years-old as a single dose for COVID-19 immunisation. Medical history included asthma and known allergies to peanuts, legumes, seasonal, animal, and various foods. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included VITAMINS, OMEPRAZOLE, CETRIZINE, AND KRI, all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 09Apr2021 at 10:15 at the age of 26-years-old as a single dose for COVID-19 immunisation. On 01May2021 at 01:00, after second shot, the patient experienced vomiting, fever, pain in joints, severe headache, lymph node swelling, pain in body, severe pain in legs, and pain at injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events experienced vomiting, fever, pain in joints, severe headache, lymph node swelling, pain in body, severe pain in legs and pain at injection site was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
hives; left foot was sore; swelling of feet; Itching of the area of rash; Rash on the armpit, upper arm, side of abdomen, buttocks and upper thigh; Ring like rash at the injection site; Headaches in the morning; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives), PAIN IN EXTREMITY (left foot was sore), PERIPHERAL SWELLING (swelling of feet), RASH PRURITIC (Itching of the area of rash) and RASH (Rash on the armpit, upper arm, side of abdomen, buttocks and upper thigh) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN and PIOGLITAZONE for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced RASH PRURITIC (Itching of the area of rash), RASH (Rash on the armpit, upper arm, side of abdomen, buttocks and upper thigh), VACCINATION SITE RASH (Ring like rash at the injection site) and HEADACHE (Headaches in the morning). On an unknown date, the patient experienced URTICARIA (hives), PAIN IN EXTREMITY (left foot was sore) and PERIPHERAL SWELLING (swelling of feet). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, URTICARIA (hives), PAIN IN EXTREMITY (left foot was sore), PERIPHERAL SWELLING (swelling of feet), RASH PRURITIC (Itching of the area of rash), RASH (Rash on the armpit, upper arm, side of abdomen, buttocks and upper thigh) and VACCINATION SITE RASH (Ring like rash at the injection site) outcome was unknown and HEADACHE (Headaches in the morning) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Significant follow-up. Events added urticaria, pain in extremity and peripheral swelling.
Shingles; Information has been received regarding a case in litigation from a lawyer, a male patient of unknown age, and his spouse. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the zoster vaccine live (ZOSTAVAX) vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 10-NOV-2015, at age 62, the patient was administered the zoster vaccine live (ZOSTAVAX) vaccine by a pharmacist at a pharmacy (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a physician for the following injury resulting from his zoster vaccine live (ZOSTAVAX) use: Shingles. The patient claimed damages as a result of: injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown.  Additional information has been requested.
Fever with temperature of 102.4F; Chills; Body aches; sore joints; Vomiting; The patient received the second dose 19 days from the first dose; This is a spontaneous report from a contactable nurse (patient). A 28-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as Covid 19 vaccine), first dose intramuscular right arm on 17Dec2020 17:30 [05:30 PM](Ej1685; expiration date: unknown) at a single dose and second dose intramuscular right arm on 05Jan2021 17:30 [05:30 PM] (lot number: EK9231; expiration date: unknown) at a single dose for covid-19 vaccination. The patient's medical history was not reported. Concomitant medication included birth control medication. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with covid-19 prior to vaccination. The patient experienced fever with temperature of 102.4F, chills, body aches, sore joints and vomiting on 06Jan2021 01:00. The patient received the second dose on 05Jan2021 17:30 which was 19 days from the first dose. The patient did not received treatment for the adverse event. The patient has not tested for COVID-19 since the vaccination. The reporter assessed the events as non-serious. The outcome of the events was not recovered.
Information has been received from a 20 year old female consumer, for the Pregnancy Registry for GARDASIL, concerning herself, who in October 2007, was vaccinated with a dose of GARDASIL, injection. In April 2008 the patient received a third dose of GARDASIL. Concomitant therapy included vitamins (unspecified). Subsequently, she became pregnant, and the last menstrual period is 11-MAY-2008. The patient had blood work performed several times during her pregnancy, results not reported. On 17-SEP-2008, the patient's placenta ruptured. The patient experienced a blood clot between her uterus and placenta, a tear in her placenta and her umbilical cord was partially attached on the side. The baby was delivered, was too small and died. The patient was hospitalized for a day after giving birth. Additional information has been requested.  3/10/09 MR received for DOS 9/17-18/2008 with D/C DX:  Premature ROM. Previable fetus.  Marginal abruption.  SVD.  Pt presented at 19 wks of pregnancy with cramping, vaginal bleeding and rupture of membranes. Non-viable fetus delivered.  Pt had retained products of conception tx with D&C. Unremarkable post-op course.
Overtired; Pain at the injection site; Chills; Body aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site), CHILLS (Chills), MYALGIA (Body aches), PYREXIA (Fever) and FATIGUE (Overtired) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site), CHILLS (Chills), MYALGIA (Body aches) and PYREXIA (Fever). On 26-Jan-2021, the patient experienced FATIGUE (Overtired). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site), CHILLS (Chills), MYALGIA (Body aches), PYREXIA (Fever) and FATIGUE (Overtired) outcome was unknown.            Concomitant medications details were not reported by the reporter. Treatment details was not reported by the reporter.
Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). On 16-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. The vials were stored in the freezer and taken out of the freezer and placed in the refrigerator on the date of administration. The vials did not undergo any temperature excursions.
Patient was not on scheduled list today. Approached this writer and staff asking for his second vaccine.  He stated he received his first dose of Pfizer in July at Pharmacy. Staff screened patient, and asked him again if he received a first dose of Pfizer. Patient stated he had received Pfizer.  Second dose was given.  After returning to office and entering dose in system it was discovered patient had actually received Moderna vaccine in July. Staff of jail advised.
Pt reports receiving her 4th Moderna dose of the COVID vaccine last week and the next day got an odd looking rash.  She was seen by a dermatologist and was diagnosed with Shingles.
Inflammation in joints, pain, rash, now developed HSP with painful rash. Treatment has included months of Steriod treatment. I keep telling healthcare providers I believe this stems from the vaccine.
On April 12th I awoke with itchy red bumps on both of my arms. I made an appointment with my doctor that morning who thought it could be a reaction to the COVID-19 vaccination I had received 6 days prior. I was sent home with a topical steroid cream and instructed to monitor the reaction. As the day went on the bumps began to spread all over my arms, legs, and stomach. The following morning many of the bumps had turned into large, welt like lesions that were itchy and painful. It felt like my skin was on fire and I could not sleep or take care of my child. Every 12 hours I had 20-30 new lesions. On April 14th my doctor prescribed Prednisone to try to control the reaction as my spots now numbered close to 100. The Prednisone did stop new lesions from emerging and gradually helped the existing spots stop itching and go away. By the end of my Prednisone course any spots that were left were faint and did not reemerge when the medication ended.
About 15 seconds after the vaccine my arm and my hand started to go numb.  Later that night i started to have a throbbing pain around the injection site.  On the 22nd I still had pain in the injection area.  I put hot and cold compresses on it.  On the morning of the 23rd I woke up with a migraine headache and a low grade fever.  I was also extremely hot.  I also was very tender and sore in the arm.  I took 2 Excedrin migraine medications.   The hot sensation did not go away.  It was so bad that even a fan did not help.  My doctor stated that I had lymph nodes that were swollen and inflamed.    The Excedrin took away the migraine but not the feeling of being hot.  On the 21st, I also felt very lethargic after the vaccine.   I stayed out of work on the 22nd.  I was sent home on the 23rd from work due to the symptoms I was having.  I also had swelling under my arm as well.  This past Sunday was the first day that I was able to do my normal activities.
Approximately one week after first dose in Covid vaccine series, I started to develop redness, heat, swelling, itching, and pain at the injection site. The injection site had been tender to the touch in previous days.  It resolved within a couple days.  I?m 24 hours into my second dose in my right arm abs am also experiencing redness, itching, and pain in my injection site. No other symptoms.
13 mth old male received MMR #1, Varicella #1 on 6/15/09. Presented with c/o rash all over body, seen at ER, Measles IgM, IgG titers sent from ER, 7/10/09 (+u), followed up at PCP's office 2 days later, rash subsides, of suspected Measles repeat IgM, IgG titers sent on 7/15/09. (+) IgG titers.
pt recv vax 13AUG97 & 20AUg97 pt exp a rash on stomach & back;
Mother reports that 2 days after vaccination, patient developed 2 non-vesicular red raised 3 mm bumps; one on arm at injection site and one on side of chest - now resolved.
Vaccinations given with patient laughing, bright affect.  After vaccinations completed patient got up and moved to another seat so a sister could be vaccinated.  After setting vaccinations on table, I and nurse heard gurgling noises and turn to see patient body tense up and jerk.  Pts eyes closed.  This lasted approx. 10 seconds.  Pt then relaxed body, opened eyes and said "I got dizzy".  Had pt assessed by RN and referred to medical clinic.
Moderate pain and tenderness to arm. General weakness and malaise increasing past two days. Chills for past two days. No fever. Body aches.
The adverse event have progressed and aggravated since the date of vaccination requiring numerous doctor visits, visits with specialists and testing. Vaccine received at work site. There could have been issues in terms of the administration. The vaccine was administered on inside of left shoulder--which was odd; it felt like it struck a nerve. Immediately, the site was hurting/throbbing pain; got home and laid on the couch and took Ibuprofen. Around 2 AM awoke gasping for air; felt like couldn't breathe. Took more ibuprofen and paced the floor since could not go back to sleep because of pain. Pain continued for a few days, site was swollen; took ibuprofen. Within a few days, nerves on neck and shoulder felt on fire. Within 1-2 weeks felt sick and had possible bad case of flu. Patient sough care at Clinic; the NP commented on swelling at site. NP prescribed antibiotics and helped a little with the lung symptoms. A couple of weeks later went back and NP thought it was cellulitis and prescribed another antibiotic. The medicine, provided relief for remaining lung issues but neck and shoulders continued to bother. Followed up with the clinic at work and they thought it was an autoimmune reaction. Testing performed was not conclusive. Problems continued and started to get rashes, lump on neck, had swallowing issues, sores/lesions on arm, neck, legs, and could not breathe well. Started passing out at work and at home. On June neurologist specified that patient had a secondary autoimmune syndrome linked to vaccine; patient was diagnosed with brachial plexus neuralgia/neuropathology/Parsonage-Turner Syndrome. The tests showed that patient had High Inflammation Factor, RA=16.8. Patient started losing feeling on arm and legs; patient could not pick up even gallon of milk and started to feel weird sensations on legs, could not make tears, saliva or mucus. In October patient was diagnosed with Sjogren's syndrome; blood test were negative though. At the end of November, patient left neurologist's practice and is looking for a new one. Patient's PCP and has had numerous visits and referrals over time. Patient has gone to physical therapy, pain management (cortisol, epidural injection in neck/shoulder), spine surgeon, chiropractor and more. Patient is in chronic pain daily and still does not feel good enough to work; the adverse events have affected her mind, body and soul. Patient is scared that 1 year later she is not working and needs to be. Patient not sure what to do to get better since so far nothing has helped. Symptoms are now worse than in the beginning and even has new problems. She feels like she has aged 10 years in 1 year. In terms of symptoms, the patient reports currently also: weak arms, swelling, puffy eyes/deep circles under eyes, blurry, double vision and headaches. Patient is worried that if symptoms continue she will require home care/assistance.
Numbness and pain - bil upper extremities, Lt > Rt. Burning sensation all over body. Easy fatigability. Tingling of face. Neck pain. Left eye watering.
Pt started feeling bad on 9/10/2017 around 3pm in the afternoon. Has experienced fever of 101.7 headache, and has redness at site of injection. Advised to go to ER if not feeling better and she said she would keep me informed.
Patient came in with bloody open wound on arm. She says that it has been bleeding since receiving flu shot. Recommended that she see her doctor.
Typical arm tenderness for 3-4 days, and fatigue. However, continued on day 5 with swollen lymph nodes under left arm pit (the left arm was where the vaccine was administered).   Ear fullness, clogging, fluttering sounds and popping started around day 5 and continue to the present.
Case previously recorded as MA2009-4322. Initial case report received from a health case professional via agency, on 11 NOV 2009. A male patient born on 18 May 2007 was vaccinated with 0.5 mL once of FLUVIRIN (batch no. 102125P1) i.m on 11 NOV 2009. No adverse events were reported. Agency reference no: NA09-007978.
Developed vestibular labyrinthitis. Symptoms include hearing loss in left ear, loss of balance, sensitivity to light, loss of balance, and dizziness. The inner ear/labyrinth developed an infection and caused damage to the vestibular nerve. Symptoms began on 09/13/22.
Diaherra , stomach upset,  nausea that's persisted even after the 2nd dose , going on for over 4 weeks , started taking florastor probiotics and it helps but it's still persistent
13aug90 pt vax w/2.5 ml hepta B instead of 1.0 ml.
COVID-19; Drug ineffective; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (COVID-19) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. #011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULAGLUTIDE (TRULICITY), Regular insulin, ISOPHANE INSULIN (NPH INSULIN) and GLYCERYL TRINITRATE (NITROGLYCERIN) for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19) (seriousness criterion hospitalization) and DRUG INEFFECTIVE (Drug ineffective). At the time of the report, COVID-19 (COVID-19) and DRUG INEFFECTIVE (Drug ineffective) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment product was not provided by the reporter  This is a case of Drug ineffective, lack of efficacy, with both doses given and COVID-19 diagnosed several months later. Based on current available information and the temporal association between product and the start date of the COVID-19 diagnosis a causal relationship is possible for the event of Drug ineffective.   This case was linked to MOD-2021-294145 (Patient Link).; Sender's Comments: This is a case of Drug ineffective, lack of efficacy, with both doses given and COVID-19 diagnosed several months later. Based on current available information and the temporal association between product and the start date of the COVID-19 diagnosis a causal relationship is possible for the event of Drug ineffective.